Literature DB >> 7123422

Adenosine deaminase estimations in the differentiation of pleural effusions.

F J Maritz, C Malan, I Le Roux.   

Abstract

Adenosine deaminase (ADA) estimations were performed on the pleural fluid from 368 effusions. The mean (+/-SD) ADA concentration in tuberculous effusions was 92,11 +/- 37,05 U/l, and these values were found to be highly statistically different from the 23,23 +/- 13,15 U/l in secondary malignant tumours of the pleura, the 34,86 +/- 14,2 U/l in mesotheliomas, and the 23,81 +/- 15,07 U/l in pulmonary embolism. The ADA values of 64,3 +/- 44,95 U/l in lymphoproliferative disorders were less significantly different. No statistical difference could be found between values in the tuberculous group and the ADA levels of 97,57 +/- 82 U/l found in para-infective effusions, but these could be distinguished from each other by microscopic examination of the pleural fluid. The importance of ADA estimations in the diagnosis and differentiation of tuberculous effusions is discussed and the role of microscopy is emphasized.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7123422

Source DB:  PubMed          Journal:  S Afr Med J


  4 in total

1.  The comparison of adenosine deaminase activity values with polymerase chain reaction results in patients with tuberculosis.

Authors:  O Canbolat; S Ulusdoyuran; G Ozgen; I Ceyhan; F Gümüşlü; A Akbay
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  Antigen capture assay for detection of a 43-kilodalton Mycobacterium tuberculosis antigen.

Authors:  A A Wadee; L Boting; S G Reddy
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

3.  Tuberculous pleural effusions: increased culture yield with bedside inoculation of pleural fluid and poor diagnostic value of adenosine deaminase.

Authors:  G Maartens; E D Bateman
Journal:  Thorax       Date:  1991-02       Impact factor: 9.139

4.  Use of adenosine deaminase as a diagnostic tool for tuberculous pleurisy.

Authors:  L J Burgess; F J Maritz; I Le Roux; J J Taljaard
Journal:  Thorax       Date:  1995-06       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.